22,973 results on '"Meningioma"'
Search Results
2. Fractionated Radiotherapy With Stereotactic Radiosurgery Boost Controls Gross Disease in Grade 2 Meningioma
3. Determination of acylcarnitines in intact brain tumors using coated blade spray mass spectrometry (CBS-MS)
4. Cognition in Meningioma: Effects of Tumor Location and Tumor Removal
5. Ophthalmic Artery Feeders in Meningioma Reduce the Effectiveness of Transarterial Embolization With n-Butyl Cyanoacrylate
6. Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
7. Traumatic Brain Injury Increasing Risk of Meningioma? From the Genetic Evidence
8. Immunohistochemistry expression of stem cell markers SOX2, OCT4, CD133 in different grades of meningiomas and correlation with Ki 67 index
9. Functional outcome after introduction of hemilaminectomy in management of spinal schwannomas and meningiomas
10. Taste dysfunction after endoscopic endonasal resection of olfactory groove meningioma: Case series and review of the literature
11. Automated volumetry of meningiomas in contrast-enhanced T1-Weighted MRI using deep learning
12. One-step orbit reconstruction using PMMA implants following hyperostotic sphenoid wing meningioma removal: Evolution of the technique in short clinical series
13. Extensive androgen exposure and meningioma risk – A matched cohort study
14. Diagnostic considerations of tumors of the sellar region according to their geometry and vector growth
15. Posterior cranial fossa meningiomas: Comparison of results between patients older and younger than 70 years
16. En plaque meningioma of the temporal bone: A systematic review on the imaging and management of a rare tumor
17. A potential role of mechano-gated potassium channels in meningioma-related seizures
18. RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups.
19. Feasibility of Acquiring Hyperpolarized Imaging in Patients with Meningioma
20. Rare CNS Tumors Outcomes &Risk
21. Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
22. Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema (AFBTEdema)
23. Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
24. A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma
25. Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
26. Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
27. Proteomic Analysis of Patients Undergoing Bariatric Surgery
28. Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
29. Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)
30. A Study of ONC201 for Refractory Meningioma
31. Post-Operative Dosing of Dexamethasone in Patients with Brain Tumors After a Craniotomy, PODS Trial
32. Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas
33. Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
34. Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
35. Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
36. Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma (SRS-AIM)
37. Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation (001_2024_BO2)
38. Robot-Assisted Neurovascular Intervention
39. Cryoablation of Brain Neoplasm
40. Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: an Open-label Randomized 1:1 Phase III Study (COG-PROTON-01)
41. 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. (DOMINO-START)
42. An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
43. Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
44. A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma
45. Cabozantinib for Patients With Recurrent or Progressive Meningioma
46. Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study (HiPPI)
47. Neurocognitive Impact of Different Irradiation Modalities for Patients with Grade I-II Skull Base Meningioma (CANCER-COG)
48. Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
49. Measuring and Mapping Cognitive Decline After Brain Radiosurgery (CoDeB-Rad)
50. Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.